Unknown

Dataset Information

0

Treatment of established TH2 cells with 4?8c, an inhibitor of IRE1?, blocks IL-5 but not IL-4 secretion.


ABSTRACT:

Background

T cell activation induces ER stress and upregulates Inositol Requiring Enzyme 1 alpha (IRE1?), an activator of the unfolded protein response (UPR) pathway. Inhibition of IRE1? RNase activity in activated CD4+ splenocytes from naïve mice, via treatment of the cells with the commercially available drug 4?8c upon activation, results in the reduction of the secretion of proteins IL-5, IL-4, and IL-13. Prior to this work, it was unknown if 4?8c could inhibit TH2 cytokines in established TH2 cells, cells that are crucial in promoting disease in severe asthma.

Results

Treatment of a mouse T helper (TH)2 cell line and differentiated human TH2 cells with 4?8c resulted in inhibition of IL-5, but not IL-4, as measured by ELISA. The reduced cytokine expression was not due to differences in mRNA stability or mRNA levels; it appears to be due to a defect in secretion, as the cells produce cytokines IL-5 as measured by flow cytometry and western blot.

Conclusion

These data suggest that the inhibition of IL-5 was due to post-translational processes. IL-5 promotes chronic, inflammatory asthma, and 4?8c blocks its expression in T cells in vitro. Future studies will determine if 4?8c treatment can ameliorate the effects of the cytokine IL-5 in a disease model.

SUBMITTER: Poe C 

PROVIDER: S-EPMC6327572 | biostudies-literature | 2019 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Treatment of established TH2 cells with 4μ8c, an inhibitor of IRE1α, blocks IL-5 but not IL-4 secretion.

Poe Cody C   Youngblood Cheyanne C   Hodge Karissa K   Kemp Kyeorda K  

BMC immunology 20190110 1


<h4>Background</h4>T cell activation induces ER stress and upregulates Inositol Requiring Enzyme 1 alpha (IRE1α), an activator of the unfolded protein response (UPR) pathway. Inhibition of IRE1α RNase activity in activated CD4<sup>+</sup> splenocytes from naïve mice, via treatment of the cells with the commercially available drug 4μ8c upon activation, results in the reduction of the secretion of proteins IL-5, IL-4, and IL-13. Prior to this work, it was unknown if 4μ8c could inhibit TH2 cytokine  ...[more]

Similar Datasets

| S-EPMC5661992 | biostudies-literature
| S-EPMC10192531 | biostudies-literature
| S-EPMC5225035 | biostudies-literature
| S-EPMC4250132 | biostudies-literature
2014-07-16 | GSE58866 | GEO
2014-07-16 | E-GEOD-58866 | biostudies-arrayexpress
2023-04-30 | GSE228327 | GEO
| S-EPMC5595963 | biostudies-literature
| S-EPMC5798347 | biostudies-literature